Anal Cancer Prevention Update and the Role of HPV Vaccination in Persons with HIV

AETC New England
6/13/22, 3:30 PM
America/New York GMT -4 summer

Description

Persons with HIV are disproportionately affected by anal cancer. This burden remains higher even in the setting of effective anti-retroviral therapies. The ANCHOR study recently announced that a screen and treat strategy for anal cancer precursors is an effective strategy to reduce the anal cancer burden in this population. We will discuss clinical strategies for anal cancer prevention and explore whether HPV vaccines will reduce the cancer burden in this population and if vaccines have a role in the prevention of other HPV-caused cancers.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Anal Cancer Prevention Update and the Role of HPV Vaccination in Persons with HIV

Inglês

 

Speakers

Grant Ellsworth

 

Link to the Event

Banner to the Event

Anal Cancer Prevention Update and the Role of HPV Vaccination in Persons with HIV